MOLECULAR MARKERS IN PREDICTING THE OUTCOME OF DIFFUSE GLIOMA GRADE 4 TREATMENT
The level of MGMT expression is considered a significant factor for prognosing GMB patients' survival. Patients with a low level of MGMT expression are considered candidates for efficient therapy with alkylating agents.
Authors
- Oleksandr Glavatskyi
- Pedachenko Eg (ORCID: https://orcid.org/0000-0003-4759-6019)
- Oksana Zemskova (ORCID: https://orcid.org/0000-0001-9462-8330)
- Т. А. Малышева (ORCID: https://orcid.org/0000-0003-4071-8327)
- Irina Shuba
- О И Цюбко
- Н. Г. Чопик
- I. G. Vasylieva
- Anna A. Shmelova
- L.M. Yakovenko
Institutions
- Romodanov Neurosurgery Institute of the National Academy of Medical Sciences of Ukraine (UA)
Publication Details
- Journal
- Experimental Oncology
- Published
- 2025-10-07
- DOI
- https://doi.org/10.15407/exp-oncology.2025.02.216
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00